173 related articles for article (PubMed ID: 7888829)
1. Current status and future perspectives in the treatment of low-grade non-Hodgkin's lymphomas.
Hiddemann W; Unterhalt M
Blood Rev; 1994 Dec; 8(4):225-33. PubMed ID: 7888829
[TBL] [Abstract][Full Text] [Related]
2. [Low-grade malignant non-Hodgkin lymphomas--current status and trends in therapy].
Hiddemann W
Ther Umsch; 1996 Feb; 53(2):123-32. PubMed ID: 8629262
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of low-grade non-Hodgkin lymphomas].
Hiddemann W; Unterhalt M; Wörmann B
Praxis (Bern 1994); 1996 Mar; 85(12):357-63. PubMed ID: 8643898
[TBL] [Abstract][Full Text] [Related]
4. Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the Working Formulation.
Pittaluga S; Bijnens L; Teodorovic I; Hagenbeek A; Meerwaldt JH; Somers R; Thomas J; Noordijk EM; De Wolf-Peeters C
Blood; 1996 May; 87(10):4358-67. PubMed ID: 8639796
[TBL] [Abstract][Full Text] [Related]
5. Non-Hodgkin's lymphomas--current status of therapy and future perspectives.
Hiddemann W
Eur J Cancer; 1995 Dec; 31A(13-14):2141-5. PubMed ID: 8652232
[TBL] [Abstract][Full Text] [Related]
6. Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.
Unterhalt M; Herrmann R; Tiemann M; Parwaresch R; Stein H; Trümper L; Nahler M; Reuss-Borst M; Tirier C; Neubauer A; Freund M; Kreuser ED; Dietzfelbinger H; Bodenstein H; Engert A; Stauder R; Eimermacher H; Landys K; Hiddemann W
Leukemia; 1996 May; 10(5):836-43. PubMed ID: 8656680
[TBL] [Abstract][Full Text] [Related]
7. Progress in the management of high risk non-Hodgkin's lymphomas. 10 years of experience of the 3rd Medical Department of Hanusch Hospital, Vienna.
Heinz R; Hanak H; Stacher A
Klin Wochenschr; 1985 Jul; 63(14):619-26. PubMed ID: 3839867
[TBL] [Abstract][Full Text] [Related]
8. The non-Hodgkin's lymphomas: pathology, staging, treatment.
Hoppe RT
Curr Probl Cancer; 1987; 11(6):363-447. PubMed ID: 3125008
[TBL] [Abstract][Full Text] [Related]
9. Low grade malignant non-Hodgkin's lymphomas and peripheral pleomorphic T-cell lymphomas in childhood--a BFM study group report.
Bucsky P; Feller AC; Reiter A; Beck J; Bertram U; Eschenbach C; Gerein V; Lakomek M; Stollmann B; Tausch W
Klin Padiatr; 1990; 202(4):258-61. PubMed ID: 2203939
[TBL] [Abstract][Full Text] [Related]
10. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.
Brittinger G; Bartels H; Common H; Dühmke E; Fülle HH; Gunzer U; Gyenes T; Heinz R; König E; Meusers P
Hematol Oncol; 1984; 2(3):269-306. PubMed ID: 6384008
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of low-grade non-Hodgkin's lymphoma].
Heinz R; Hopfinger-Limberger G
Wien Klin Wochenschr; 1994; 106(10):321-6. PubMed ID: 8053200
[TBL] [Abstract][Full Text] [Related]
12. Rationale for consolidation to improve progression-free survival in patients with non-Hodgkin's lymphoma: a review of the evidence.
Morschhauser F; Dreyling M; Rohatiner A; Hagemeister F; Bischof Delaloye A
Oncologist; 2009; 14 Suppl 2():17-29. PubMed ID: 19819921
[TBL] [Abstract][Full Text] [Related]
13. [Radiotherapy alone in early stages of low malignancy non-Hodgkin lymphomas].
Engelhard M; Sack H
Praxis (Bern 1994); 1998 Jun; 87(23):801-5. PubMed ID: 9654986
[TBL] [Abstract][Full Text] [Related]
14. Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: a clinicopathological comparison between tonsillar and non tonsillar lymphomas. (Hellenic co-Operative Oncology Group).
Economopoulos T; Fountzilas G; Kostourou A; Daniilidis J; Pavlidis N; Andreopoulou H; Nicolaou A; Papageorgiou E; Mellou S; Dervenoulas J; Stathakis N
Anticancer Res; 1998; 18(6B):4655-60. PubMed ID: 9891536
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.
Hagenbeek A; Carde P; Meerwaldt JH; Somers R; Thomas J; De Bock R; Raemaekers JM; van Hoof A; De Wolf-Peeters C; van Glabbeke M
J Clin Oncol; 1998 Jan; 16(1):41-7. PubMed ID: 9440721
[TBL] [Abstract][Full Text] [Related]
16. High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry.
Williams CD; Harrison CN; Lister TA; Norton AJ; Blystad AK; Coiffier B; Taghipour G; Schmitz N; Goldstone AH;
J Clin Oncol; 2001 Feb; 19(3):727-35. PubMed ID: 11157024
[TBL] [Abstract][Full Text] [Related]
17. Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosis.
Akerman M; Brandt L; Johnson A; Olsson H
Br J Cancer; 1987 Feb; 55(2):219-23. PubMed ID: 3814492
[TBL] [Abstract][Full Text] [Related]
18. [NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 1: Classification and allocation to strategic therapy groups. BIF study group].
Reiter A; Tiemann M; Ludwig WD; Wacker HH; Yakisan E; Schrappe M; Henzler D; Sykora KW; Brandt A; Odenwald E
Klin Padiatr; 1994; 206(4):222-33. PubMed ID: 7967418
[TBL] [Abstract][Full Text] [Related]
19. Durability of remission after ABMT for NHL: the importance of the 2-year evaluation point.
Bolwell B; Goormastic M; Andresen S
Bone Marrow Transplant; 1997 Mar; 19(5):443-8. PubMed ID: 9052909
[TBL] [Abstract][Full Text] [Related]
20. Inroads in the therapy of indolent lymphomas: exploiting biological insights.
McLaughlin P
Cancer Invest; 1999; 17(1):73-86. PubMed ID: 10999051
[No Abstract] [Full Text] [Related]
[Next] [New Search]
